Plant Extracts Stabilizing FGF-2 Against Degradation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies lack effective means to protect Fibroblast Growth Factor (FGF-2) from degradation, particularly at the skin level, which is crucial for maintaining skin integrity and addressing aging-related changes.

Innovation Solution

Development of plant-derived active ingredients that mimic the protective action of heparan sulfate proteoglycans to stabilize FGF-2, allowing it to cross the skin barrier and maintain its activity, thereby preventing degradation and promoting skin renewal and repair.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If FGF-2 is applied to skin without protection, then it can potentially stimulate skin cell proliferation and collagen synthesis, but it undergoes rapid thermal and enzymatic degradation at the skin level

Engineering Contradiction:
Improvestability of FGF-2VSAvoidthermal and enzymatic degradation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs plant-derived compounds (such as flavonoids, phenolic acids, and terpenoids) as intermediary substances that bind to FGF-2 and form protective complexes. These intermediary compounds shield the growth factor from thermal and enzymatic degradation at the skin level, thereby enhancing its stability and biological activity without requiring structural modification of FGF-2 itself.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent utilizes plant extracts containing multiple bioactive compounds that alter the chemical environment around FGF-2, changing parameters such as pH, oxidation-reduction potential, and molecular interactions. These parameter changes create a protective microenvironment that prevents degradation while maintaining FGF-2's biological function for skin regeneration.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If heparan sulfate proteoglycans are used to protect FGF-2, then stability is improved, but the complexity of the substance increases and may cause unwanted side effects

Engineering Contradiction:
Improveprotective stabilityVSAvoidmolecular complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces complex, potentially problematic heparan sulfate proteoglycans with simpler, naturally occurring plant-derived compounds that are readily biodegradable and metabolized. These plant compounds (such as quercetin, catechins, and other polyphenols) provide temporary but effective protection during the critical period of FGF-2 action, then are safely eliminated without accumulating in the system.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent identifies and utilizes plant compounds that replicate or mimic the protective binding characteristics of heparan sulfate proteoglycans without requiring the complex proteoglycan structure. These simplified molecular copies achieve similar protective effects through analogous binding mechanisms, reducing complexity while maintaining functionality.

Inventive Principle:
Principle #26Copying

3Duration of action of moving object

If FGF-2 is stabilized for prolonged activity, then duration of action is improved, but the risk of unwanted biological effects increases

Engineering Contradiction:
Improvehalf-life of FGF-2VSAvoidunwanted biological effects
Core Design Contradiction:
Duration of action of moving objectVSObject-generated harmful factors

Solution Approach 1:

The patent employs plant-derived compounds that provide partial protection to FGF-2, allowing it to remain stable long enough to exert its beneficial effects on skin cell proliferation and collagen synthesis, but not so stable that it accumulates to problematic levels. The plant compounds create a balanced protection that extends duration of action to the optimal therapeutic window without excessive persistence.

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The patent utilizes the body's natural metabolic pathways to regulate the duration of FGF-2 action. Plant-derived compounds facilitate this self-regulation by being metabolized and eliminated through normal physiological processes, allowing the body to control the duration of FGF-2 activity and prevent unwanted accumulation or prolonged effects.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The plant-derived active ingredients effectively protect FGF-2 from thermal and enzymatic degradation, maintaining its biological activity and promoting skin cell proliferation, collagen synthesis, and overall skin health, addressing skin aging and integrity issues.

Implementation Method 1

Development of plant-derived active ingredients that mimic the protective action of heparan sulfate proteoglycans to stabilize FGF-2

Methodology Applied
Scientific EffectMolecular binding/interaction:

Data Source

PatentUS9925134B2Use of substances to protect FGF-2 or FGF-beta growth factor
Publication Date: 2018.03.27 BASF BEAUTY CARE SOLUTIONS FRANCE SAS
  • US9925134B2 patent drawing
  • US9925134B2 patent drawing
  • US9925134B2 patent drawing

AI summary

The invention relates to substances which are capable of protecting FGF-2, to a composition for preventing or controlling degradation of FGF-2, and a method of protecting FGF-2 in the skin from degradation.In particular, the invention relates to an extract of Hibiscus Abelmoschus or ambrette, a rebokza extract, a gougizi berry extract, a banha extract, a lessonia extract, a mustard flour extract, a wooyin extract, a barley extract, and/or a sesame extract, in amounts effective to protect FGF-2 from its degradation.Further, the present invention allows the extracellular matrix to be restructured, particularly at the dermis, which is useful, for example, for controlling aging.